JP2026041866A5 - - Google Patents
Info
- Publication number
- JP2026041866A5 JP2026041866A5 JP2025225443A JP2025225443A JP2026041866A5 JP 2026041866 A5 JP2026041866 A5 JP 2026041866A5 JP 2025225443 A JP2025225443 A JP 2025225443A JP 2025225443 A JP2025225443 A JP 2025225443A JP 2026041866 A5 JP2026041866 A5 JP 2026041866A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate according
- linker
- dsrna
- seq
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962864755P | 2019-06-21 | 2019-06-21 | |
| US62/864,755 | 2019-06-21 | ||
| PCT/US2020/038475 WO2020257483A1 (en) | 2019-06-21 | 2020-06-18 | Structurally defined sirna-dual variable domain immunoglobulin conjugates |
| JP2021576064A JP7785543B2 (ja) | 2019-06-21 | 2020-06-18 | 構造的に明確なｓｉＲＮＡ－二重可変ドメイン免疫グロブリンコンジュゲート |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576064A Division JP7785543B2 (ja) | 2019-06-21 | 2020-06-18 | 構造的に明確なｓｉＲＮＡ－二重可変ドメイン免疫グロブリンコンジュゲート |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026041866A JP2026041866A (ja) | 2026-03-10 |
| JP2026041866A5 true JP2026041866A5 (https=) | 2026-04-24 |
Family
ID=74040502
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576064A Active JP7785543B2 (ja) | 2019-06-21 | 2020-06-18 | 構造的に明確なｓｉＲＮＡ－二重可変ドメイン免疫グロブリンコンジュゲート |
| JP2025225443A Pending JP2026041866A (ja) | 2019-06-21 | 2025-12-03 | 構造的に明確なｓｉＲＮＡ－二重可変ドメイン免疫グロブリンコンジュゲート |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576064A Active JP7785543B2 (ja) | 2019-06-21 | 2020-06-18 | 構造的に明確なｓｉＲＮＡ－二重可変ドメイン免疫グロブリンコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230049529A1 (https=) |
| EP (1) | EP3986475A4 (https=) |
| JP (2) | JP7785543B2 (https=) |
| AU (1) | AU2020295485A1 (https=) |
| CA (1) | CA3138627A1 (https=) |
| WO (1) | WO2020257483A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113512557A (zh) * | 2021-04-15 | 2021-10-19 | 山西大学 | 飞蝗脱水抗性基因LmDesi及其dsRNA的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4851940B2 (ja) * | 2004-11-19 | 2012-01-11 | 宮城県 | がんまたは糖尿病治療のための医薬組成物 |
| US20110223665A1 (en) * | 2008-07-25 | 2011-09-15 | Alnylam Pharmaceuticals, Inc. | ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| CN108025071B (zh) * | 2015-09-17 | 2022-11-01 | 斯克利普斯研究院 | 双重可变结构域免疫缀合物及其用途 |
| CA3049133A1 (en) * | 2017-01-18 | 2018-07-26 | Alnylam Pharmaceuticals, Inc. | Endosomal cleavable linkers |
-
2020
- 2020-06-18 CA CA3138627A patent/CA3138627A1/en active Pending
- 2020-06-18 JP JP2021576064A patent/JP7785543B2/ja active Active
- 2020-06-18 WO PCT/US2020/038475 patent/WO2020257483A1/en not_active Ceased
- 2020-06-18 US US17/621,029 patent/US20230049529A1/en active Pending
- 2020-06-18 AU AU2020295485A patent/AU2020295485A1/en active Pending
- 2020-06-18 EP EP20826493.7A patent/EP3986475A4/en active Pending
-
2025
- 2025-12-03 JP JP2025225443A patent/JP2026041866A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026041866A5 (https=) | ||
| JP2025000818A5 (https=) | ||
| IL274906B2 (en) | Compositions and methods for treating muscular dystrophy and myotonic dystrophy | |
| JP7803925B2 (ja) | 抗トランスフェリン受容体（ＴｆＲ）抗体およびその使用 | |
| JP2021533199A5 (https=) | ||
| JP2022122928A5 (https=) | ||
| IL317871A (en) | Muscle targeting complexes and their uses for the treatment of FACIOSCAPULOHUMERAL muscular dystrophy | |
| JP2023015095A5 (https=) | ||
| JPWO2020132584A5 (https=) | ||
| JPWO2018129384A5 (https=) | ||
| JPWO2021142227A5 (https=) | ||
| JP2021507686A5 (https=) | ||
| JP2021533197A5 (https=) | ||
| TW201825679A (zh) | 經修飾之嚮導rna | |
| JPH04211395A (ja) | 合成ヒト抗体の遺伝子バンクの製造および使用 | |
| JPWO2020028861A5 (https=) | ||
| JP2021533804A5 (https=) | ||
| JPWO2021142313A5 (https=) | ||
| IL316206A (en) | Dosage of muscle targeting complexes for the treatment of myotonic dystrophy | |
| JPWO2020028832A5 (https=) | ||
| JPWO2021142275A5 (https=) | ||
| JPWO2021142307A5 (https=) | ||
| JPWO2021142234A5 (https=) | ||
| JPWO2023283531A5 (https=) | ||
| JP2021520355A5 (https=) |